This Immunology and Pathology Laboratory Core (Core B) will serve as a centralized facility for procedures common to all of the projects in the Program Project. This core will have the capacity to perform high throughput analysis of samples generated from animals and tissue culture. The core will perform multiplexing analysis of cytokine proteins from various samples generated from serum and cell culture. It will also perform RT-PCR for detection mRNA cytokines isolated from various tissues as needed. Finally, it will perform routine and specialized immunohistochemistry on tissue samples for examination of pathological specimens. It wil also assist with sample preparation from various tissues. All three projects will use this core for some element of their analysis. This Core will be the most heavily used for the PPG. Specifically this Immunology and Pathology core will: 1) Provide standardized methods for evaluating the level of cytokine proteins and/or their RNA in fluids and tissues collected from mice, human cells or primates. Methods will include multiplexing strategies for quantitatively detecting multiple cytokines in one sample, real-time PCR techniques for quantitative detection of cytokine RNAs, ELISpot methods to determine the number of cells collected from either organs or blood producing specific cytokines 2) Provide capability in increased labor capacity to prepare samples from mice and primates for histological and cellular analysis 3) Provide capability and capacity in assisting in disruption of lung cells and evaluation of cell phenotypes of cells recovered directly from organs or tissue culture by flow cytometry techniques. Other capabilities will be to perform intracellular cytokine staining for phenotyping cells recovered animal tissues and blood or potentially tissue culture as needed.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of New Mexico
United States
Zip Code
Hutt, Julie A; Lovchik, Julie A; Drysdale, Melissa et al. (2014) Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge. Am J Pathol 184:3205-16
Lovchik, Julie A; Drysdale, Melissa; Koehler, Theresa M et al. (2012) Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax. Infect Immun 80:2414-25
Mara-Koosham, Gopi; Hutt, Julie A; Lyons, C Rick et al. (2011) Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains. Infect Immun 79:1770-8
Hansen, Spencer J; Rushton, John; Dekonenko, Alexander et al. (2011) Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection. Virology 412:411-25
Chand, Hitendra S; Schuyler, Mark; Joste, Nancy et al. (2010) Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways. J Allergy Clin Immunol 125:1157-1158.e5
Lipscomb, Mary F; Hutt, Julie; Lovchik, Julie et al. (2010) The pathogenesis of acute pulmonary viral and bacterial infections: investigations in animal models. Annu Rev Pathol 5:223-52
Borovkov, Alex Y; Loskutov, Andrey V; Robida, Mark D et al. (2010) High-quality gene assembly directly from unpurified mixtures of microarray-synthesized oligonucleotides. Nucleic Acids Res 38:e180
Wu, Terry H; Zsemlye, Jason L; Statom, Gloria L et al. (2009) Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains. Vaccine 27:4684-93
Collazo, Carmen M; Meierovics, Anda I; De Pascalis, Roberto et al. (2009) T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria. Infect Immun 77:2010-21
Hahn, Andrew C; Lyons, C Rick; Lipscomb, Mary F (2008) Effect of Bacillus anthracis virulence factors on human dendritic cell activation. Hum Immunol 69:552-61

Showing the most recent 10 out of 12 publications